Benztropine is FDA-approved as adjunctive therapy for all forms of parkinsonism. It is also used for drug-induced extrapyramidal symptoms, prevention of dystonic reactions, and treatment of acute dystonic reactions. This activity examines the indications, mechanism of action, dosing, adverse event profile, and other factors so members of the interprofessional healthcare team can make informed decisions regarding the use of benztropine.

**Objectives:**
- Identify the mechanism of action of benztropine.
- Describe the adverse effects of benztropine.
- Review the appropriate monitoring for toxicity of benztropine.
- Outline some interprofessional team strategies for improving care coordination and communication to advance the use of benztropine and improve outcomes.